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MELANOGENESIS FROM TOPICAL MECHLORETHAMINE AND 
ANALOGUES IN SKIN OF HAIRLESS MICE AND IN VITILIGO 
E. J. VAN Scon, M.D. , AND R J . Yu , PH.D. 
Department of Dermatology , Temple Uniuersity Health Sciences Center, The Skin and Cancel' Hospital of 
Philadelphia , Phi ladelphia, Pennsy luania 
Progressive repigmentation occurred in vitiliginous skin of two patients top ica lly t reated 
with aqueous solutions of mechlorethami ne. Hairless mice were found to prov ide what seems 
to be a satisfactory cutaneous system for eva luating potential melanogenic properties of 
topically app lied test compounds. 
Hyperp igmentation of the skin occurs commonly 
in patients topically treated with mechlorethamine 
(HN2, nitrogen mustard) (1 - 3), becoming manifest 
within a few weeks following initiation of daily 
topical applications and most conspicuous in per-
sons with normally dark skin or who tan readily. 
The accentuation of pigmentation has been shown 
to be associated with disaggregation of melano-
somes and increase in their numbers within mel-
anocytes [3). 
Because of the possible applicabili ty of t hese 
observations in a search for sui table agents for 
treatment of viti ligo, it is important to estab lish 
whether HN2 can provoke repigmentation in viti-
ligo and, if so, to identify a laboratory an imal with 
skin adaptable for pursuit of relevant studies. We 
report here an incidental observation of repigmen-
tation of vit iliginous skin in a patient with mycosis 
fungoides (MF) topically treated with HN2 . The 
phenomenon has been confirmed in a limited 
therapeutic attempt in another patient having 
widespread vitiligo not associated with any other 
dermatologic disorder, and we have found t hat 
marked melanogenesis can be consistently evoked 
in the hairless mouse by top ical admin istration of 
HN2 and several other compounds with chloro-
ethylamine structure. 
CLIN ICAL OBSERVATIONS 
The first patient, a 52-year-old Black man, had 
noted the onset of enlarging areas of complete 
depigmentation on the scalp , lips, trunk , gen italia, 
and all extremities over a 3-year interval in associ-
ation with photosensit ivity and t he development of 
infiltrated cutaneous plaques histologically diag-
nosed as MF. At the t ime of our first examination 
most depigmented areas were not wit hin sites of 
skin involved with MF, as determined clinically or 
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histopathologically. Phototests confirmed his light 
sens it ivity, revealing markedly low t hreshold ery-
thema doses to both UV -A (long-wave) and UV-C 
(short-wave) in sites of normally pigmented sk in . 
Following use of our routine procedure for induc-
tion of specific immunologic tolerance to HN2 
(200tLg HN2 intravenously weekly for 4 weeks [2]), 
daily whole-body topical applications of 10 mg 
HN2 dissolved in 60 cc of water were begun as 
treatment of t he mycosis fungoides. During t he 
ensuing months, in addition to resolut ion of 
plaques of MF, repigmentation of all les ions of 
vitiligo was discernible both by t he appearance of 
innumerable minute islands of pigmented skin 
within t he depigmented areas as well as by cen-
tripetal spread of pigmentation from borders. At 
the end of one year some sites had become com-
pletely repigmented, and all s ites had regained 
substantial pigmentation (Figs. 1, 2). 
The second patient was a 68-year-old Black lady 
who sought therapy for progressive vitiligo, of 5 
years' duration, which had not responded to sun-
light treatment with and without orally adminis-
tered psoralen (trioxalen), nor to topi cal applica-
tion of liquefied phenol to small test sites. It was 
agreed that the therapeutic possibilities of topical 
HN2 might best be explored by treating a com-
bined area of skin , and t he right half of the upper 
chest was selected as the site . Following t he 
above-desc ribed procedure to induce immunologic 
tolerance, the patient was instructed to prepare 
aq ueous solutions of HN2 (10 mg dissolved in 60 cc 
of tap water) which were applied with the finger 
t ips once dai ly to the right upper chest. Solutions 
were kept frozen between usages and thawed daily 
for use. Fresh solutions were prepared weekly . 
After one month, punctate repigmentation was 
discernible on the treated side and after 3 months 
substantial repigmentation was evident (Fig. 3). 
Treatment was discontinued at that t ime, how-
ever, because of t he patient's concern over the 
speckled appearance of t he repigmentation and 
because of' indefin ite projections of t ime required 
to repigment extensive skin areas . She elected to 
employ topical cosmetic preparations containing 
artificial pigments. 
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FIG. 1. Sca lp of patient with mycosis fungoides before 
topica l HN2 was start.ed (A), and 12 months aft.er daily 
hole-bodY t.opical thera py (B). Repigmentation dis-
wernible as multiple islands within vitiliginous plaque. 
~hole-body t.opical therapy (B) . Repigmentat.ion discer-
nib le as multiple islands within vitiliginous p laque. 
F IG. 2. Right. forearm of same patient before (A) and 
after (B) t.opica l HN2. Repigmentation has been co m-
p lete within one year. 
F IG. 3. Chest. of patient. with vit. iligo 3 months aft.er 
beginni ng topical HN 2. Repigmenta t ion of skin on 
treated side is readily a pparent. 
STUDIE IN HAIRLESS MICE 
Ha irless mice, stra in SKH-hr (ab), we re found to 
provide what seemed to be a satisfactory cutaneous 
system for eva luation of potentia l melanogenic 
properties of test com pounds. Test mater ia ls were 
dissolved in app ropriate solvents (aqueou , anhy-
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drous ethanol, or anhydrous ethanol-acetone) and 
topica lly applied to the midbacks of at least 3 
animals once daily, 5 days weekly, for 3 weeks . At 
t he end of this test period the presence or absence 
of grossly apparent pigmentation was determined. 
Specimens of skin from those animals rnanifesting 
TABLE. Compounds euohing melanogenesis when 
topically applied to skin of hairless mice 
Compound 
Mechloret.hamine hyd rochloride (H 2) 
Bis-(2-chl oroethyl)a min e hydrochloride 
(nor-H N2) 
Chlorambucil 
N-(2-chloroethyl) -N-(2- met hoxyet.hyl)-
benzylamine hydrochloride 
N,N-Diethyl-2-chloroethyla min e hydro-
chloride 
N,N-DiisopropYI-2-chloroethylam ine 
hydrochlori de 
oneen· 
tration 
(%) 
0.2 
5 
5 
5 
5 
FIG. 4. Untreated mouse (A) and mouse after 3 weeks 
of t.opical HN2 to back where skin is heavily pigmented 
(8). 
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FIG. 5. Section of ski n from mouse topica. lly treated 
for 3 wee ks with nonpigmentogeni c mat.e ria l C'\) and from 
mouse t.op ica lly treated with H 2 (8) showino abundant 
melanin granu les in dendritic cells of epidermis as well 
as elsewhere (Masson- Font.ana sta in. x 280). 
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pigmentation grossly were examined hi stologica lly, 
The T able lists the compounds t hat evoked 
substant ial degrees of pigm entation grossly evi -
dent by 3 weeks (Fig, 4), The pigmentation was 
histolog ically character ized by an abundance of 
pigm ent granules wi t hin dendritic cells of the 
epiderm is, pigment "dust" scattered throughout 
the ep idermis, and pigment particles in the dermis 
both intracell ula rly and extracell ul a rly, These his-
tologic feat ures were readily apparent in specimens 
stained wit h hematoxylin and eos in , but were most 
clearly demonstrable in sections sta ined by t he 
Masson- Fontana technique (Fig, 5), 
T he following compounds in concent rations of 
up to 5% were not pigmentogenic when topically 
a pplied on ha irless mice for 3 weeks: az iridine, 
6-azauridine, acetylcholine chloride, 5- bromoura-
cil , chlorocholine chloride, 2-chloroethylamine hy-
droc hloride, N-(2-chloroethyl)- pyrrolidine hyd ro-
chloride, N-(2-chloroethyl)-p iperidine hyd rochlo-
ride, N-(2-chloroethyl) -morpholine hydrochloride, 
N-(2-chloroethyl)-hexa methylene imine hydrochlo-
ride, 7-(2-chloroethyl )-theophylline, choline chlo-
rid e, N,N-d ibenzyl-2-chloroethyla mine hydrochlo-
ride, N,N-dimethyl-2-chloroethylamine hydrochlo-
ride, di ethanolam ine, Diaza ld , 5-fluorourac il, N -
methyl-2-c hloroethyl -2 -hydroxyet hyla min e, N -
methyld iethanolamine, N-methylethanolamine 1-
ni trosopyrrolidine, and N-nitrosodimethyla min'e, 
P igmentation of vit iliginous skin by H N2, and of 
the ski n of the hairless mice by t he six compounds 
listed in t he Table, appeared to be a rather spec ific 
response rather than one due to postinflammatory 
pigmentation. Although direct data on this point 
a re not ava ilable, the following are importa nt: (1) 
the patients topica lly t reated wi t h HN2 showed no 
cl inical ev idence of erythema, and (2) while many 
of t he com pounds tested on ha irless mice produced 
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erythema and scaling, only the six lis ted evoked 
discernible degrees of melanization, 
DISCUSSION 
These observations indicate that HN2 and a 
number of related chemicals with particula r mo-
lecula r configuration are profoundly stimulatory of 
cuta neous melanogenes is in huma ns and ha irless 
mice, Thera peutic utility of HN2 for possible 
therapy of vi t iligo is compromised by its antigenic-
ity in m an [4 ) and its possible carcinogenicity as 
extrapola ted from animal studies [5,6). The obser-
vations reported herein, however, suggest that the 
skin of hairless mice may provide a relia ble system 
for identifying melanogeni c chemicals more appro-
pr iate for inducing melanogenesis in pigmentary 
disorders of humans- chemica ls which by other 
tests can be qualified according to t heir potent ia l 
a llergenicity and carcinogenic ity , 
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